SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-14-167213
Filing Date
2014-04-29
Accepted
2014-04-29 16:18:10
Documents
2
Period of Report
2014-06-19
Effectiveness Date
2014-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d713783ddef14a.htm DEF 14A 434374
2 GRAPHIC g713783g50m44.jpg GRAPHIC 24343
  Complete submission text file 0001193125-14-167213.txt   469252
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36150 | Film No.: 14794135
SIC: 8731 Services-Commercial Physical & Biological Research